{"gene":"CUX1","run_date":"2026-04-28T17:28:53","timeline":{"discoveries":[{"year":2004,"finding":"A nuclear isoform of cathepsin L, devoid of a signal peptide (translated from downstream AUG sites), localizes to the nucleus during the G1-S transition and proteolytically processes the CDP/CUX transcription factor to generate the p110 isoform, thereby regulating cell cycle progression.","method":"Immunofluorescence imaging, activity-based probe labeling, ectopic expression of cathepsin L, Cat L-/- cell analysis, in situ processing assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (imaging, genetic KO, activity-based probes, ectopic expression) in a single rigorous study","pmids":["15099520"],"is_preprint":false},{"year":2006,"finding":"A 90 kDa CUX1 isoform (p90) is generated by cathepsin L proteolytic processing; its steady-state level correlates with cathepsin L activity, and it shares similar DNA-binding and transcriptional activities with p110.","method":"Deletion mapping, Western blot, co-expression with cathepsin L mutants","journal":"Biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2-3 — mapping and biochemical assays in a single lab, multiple constructs tested","pmids":["16972798"],"is_preprint":false},{"year":2002,"finding":"A shorter CUX1 isoform, p75, is generated by transcription initiation within intron 20 and contains only Cut repeat 3 and the Cut homeodomain; it can repress the p21 promoter and activate a DNA polymerase alpha reporter, and its aberrant expression in mammary epithelial cells is associated with altered differentiation.","method":"Reporter assays, stable cell expression, RT-PCR, cell morphology/collagen assays","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2-3 — multiple functional assays, single lab","pmids":["12438259"],"is_preprint":false},{"year":2006,"finding":"The p110 CDP/CUX isoform accelerates entry into S phase by shortening G1 by 2-4 hours; it upregulates cyclin E2 and A2, and its loss in Cutl1z/z MEFs prolongs G1 and reduces proliferation.","method":"Stable cell populations with p110, synchronization experiments (growth factor deprivation, thymidine block, centrifugal elutriation), MEF genetic inactivation, focus formation and tumor growth assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — multiple synchronization paradigms plus genetic KO with consistent phenotypic readouts","pmids":["16508018"],"is_preprint":false},{"year":2008,"finding":"p110 CUX1 cooperates with E2F1 and E2F2 in transcriptional activation of cell cycle genes including DNA polymerase alpha; p110 engages in protein-protein interactions with E2F1/E2F2, promotes their recruitment to target promoters, and a low-affinity E2F binding site is required for this activation.","method":"Tandem affinity purification, co-immunoprecipitation, chromatin immunoprecipitation, linker-scanning analysis, reporter assays, genome-wide location analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 — TAP, CoIP, ChIP, and reporter assays with multiple orthogonal methods in a single study","pmids":["18347061"],"is_preprint":false},{"year":1999,"finding":"CUX1/CDP is a component of NF-μNR and represses the immunoglobulin heavy chain intronic enhancer (Eμ) by binding to MAR sequences and antagonizing the Bright transcription activator at both the DNA-binding and functional levels.","method":"Expression library screening, EMSA, co-immunoprecipitation, antiserum recognition, cotransfection/reporter assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (EMSA, CoIP, reporter assays) consistently demonstrating mechanism","pmids":["9858552"],"is_preprint":false},{"year":1999,"finding":"CUX1/CDP interacts with SATB1 through its Cut repeats (CR1, CR2, and homeodomain); this interaction prevents each protein from binding DNA and CUX1 overexpression in T cells neutralizes SATB1-mediated repression of the MMTV promoter.","method":"GST pull-down, co-immunoprecipitation with specific antisera, Far-Western blot, gel retardation assay, reporter assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal in vitro and cell-based methods","pmids":["10373541"],"is_preprint":false},{"year":2014,"finding":"CUX1 functions as an ancillary factor in base excision repair by directly stimulating the enzymatic activity of 8-oxoG-DNA glycosylase OGG1; Cux1+/- MEFs are haploinsufficient for repair of oxidative DNA damage, whereas elevated CUX1 accelerates repair. CUX1 prevents RAS-induced senescence and is synthetic lethal with oncogenic RAS.","method":"In vitro BER assay with purified proteins, single-cell gel electrophoresis (comet assay), MEF haploinsufficiency analysis, RNAi synthetic lethality, transgenic mouse models","journal":"PLoS biology","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro BER assay with purified components plus multiple genetic and cellular validations","pmids":["24618719"],"is_preprint":false},{"year":2015,"finding":"A single CUT repeat domain of CUX1 is sufficient to stimulate DNA binding, Schiff-base formation, glycosylase, and AP-lyase activities of OGG1; Cux1-/- MEFs cannot proliferate in 20% O2 but proliferate normally in 3% O2, rescued by ectopic CUX1 or a recombinant Cut repeat protein devoid of transcriptional activity.","method":"In vitro enzymatic assays with purified proteins, genetic rescue with structure-function constructs, MEF proliferation assays under different oxygen levels","journal":"Oncotarget","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with purified domains plus structure-function analysis and genetic rescue","pmids":["25682875"],"is_preprint":false},{"year":2018,"finding":"CUX1 CUT domains stimulate APE1 (apurinic/apyrimidinic endonuclease 1) enzymatic activity; CUX1 knockdown increases abasic sites and decreases APE1 activity in cell extracts, while CUX1 overexpression or a two-CUT-domain protein increases APE1 activity and resistance of glioblastoma cells to temozolomide.","method":"In vitro DNA repair assay with purified proteins, abasic site quantification in genomic DNA, cell extract APE1 activity assay, clonogenic survival with CUX1 KD/OE","journal":"Neuro-oncology","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro reconstitution with purified CUT domains plus concordant cell-based functional assays","pmids":["29036362"],"is_preprint":false},{"year":2017,"finding":"CUX1 is rapidly recruited to sites of DNA damage; a recombinant protein containing only two CUT domains is sufficient for this recruitment, accelerates DNA repair, and increases clonogenic survival following ionizing radiation.","method":"Clonogenic survival assay, CUX1 KD/OE, recombinant CUT domain protein rescue, DNA damage focus analysis","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2-3 — structure-function with recombinant proteins plus cellular assays, single lab","pmids":["28147323"],"is_preprint":false},{"year":2012,"finding":"CUX1 regulates the constitutive expression of ATM and ATR and genes involved in damage-induced signaling through them; CUX1 knockdown or genetic inactivation reduces ATM autophosphorylation, phospho-Chk2, p53 levels, γ-H2AX/Rad51 foci, and compromises DNA strand break repair and cell cycle checkpoints.","method":"RNAi knockdown, genetic inactivation, immunofluorescence for DNA damage foci, phosphoprotein analysis, genome-wide expression profiling","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 — genome-wide approach plus multiple functional readouts, single lab","pmids":["22319212"],"is_preprint":false},{"year":2010,"finding":"CUX1 and CUX2 are intrinsic and complementary regulators of dendrite branching, spine development, and synapse formation in layer II-III cortical neurons; Cux genes control dendritic spine number and maturation partly through direct regulation of Xlr3b and Xlr4b expression, and Cux2-/- mice show reduced synaptic function and working memory defects.","method":"Knockout and knockdown mice, morphological, molecular, and electrophysiological analysis","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 — genetic KO combined with morphological, molecular, and electrophysiological readouts across multiple labs/publications","pmids":["20510857"],"is_preprint":false},{"year":2010,"finding":"Increasing Cux1 (but not Cux2) expression reduces dendritic complexity of cortical pyramidal neurons, while reducing Cux1 promotes dendritic arborization; this effect requires the DNA-binding domains and acts primarily through suppression of p27Kip1, with RhoA as a downstream mediator.","method":"In vitro neuronal cultures with gain/loss of function, immunofluorescence for dendritic morphology, signaling pathway analysis","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2-3 — gain and loss of function with pathway analysis, single lab","pmids":["20485671"],"is_preprint":false},{"year":2009,"finding":"Cux1 directly interacts with the co-repressor Grg4 (Groucho 4) to enhance repression of p27Kip1; both Cux1 and Grg4 (along with HDAC1 and HDAC3) are recruited to the p27Kip1 promoter in vivo, and Cux1 binds directly to the p27Kip1 promoter at two sites identified by DNase I footprinting.","method":"Co-immunoprecipitation, promoter luciferase assay, ChIP in kidney tissue, DNase I footprinting","journal":"Gene","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including in vivo ChIP and in vitro footprinting confirming direct binding","pmids":["19332113"],"is_preprint":false},{"year":2020,"finding":"CUX1 mediates the synergistic inflammatory response to TNF and IL-17A in synovial fibroblasts by binding a unique CUX1-NF-κB motif in the promoters of CXCL1, CXCL2, and CXCL3 and cooperating with NF-κB p65 to drive their transcription, independent of LIFR, STAT3, STAT4, and ELF3.","method":"Gene silencing transcriptomics, siRNA knockdown, promoter motif analysis, functional reporter assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2-3 — multiple gene-silencing experiments with defined transcriptional readouts, single lab","pmids":["32079724"],"is_preprint":false},{"year":2009,"finding":"CUX1 expression is induced by PI3K/Akt signaling and decreased by PI3K inhibitors; CUX1 exerts anti-apoptotic activity by upregulating BCL2 and downregulating TNFα, conferring resistance to TRAIL- and drug-induced apoptosis in pancreatic cancer cells.","method":"CUX1 overexpression and knockdown, Akt pathway activation/inhibition, caspase activity assays, PARP cleavage, xenograft model with siRNA nanoparticles","journal":"Gut","confidence":"Medium","confidence_rationale":"Tier 2-3 — multiple functional assays with both gain and loss of function, single lab","pmids":["20442202"],"is_preprint":false},{"year":2009,"finding":"CUX1 regulates several Wnt genes and is involved in establishing a Wnt/β-catenin autocrine loop in mammary tumors; CUX1 transcriptionally regulates Wnt genes as demonstrated by ChIP, shRNA-mediated knockdown, and reporter assays.","method":"Chromatin immunoprecipitation, shRNA knockdown, reporter assays, transgenic mouse mammary tumor analysis","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP, functional knockdown, and reporter assays, single lab","pmids":["19738070"],"is_preprint":false},{"year":2014,"finding":"CUX1 and GLIS1 cooperate to stimulate TCF/β-catenin transcriptional activity and enhance cell migration and invasion; elevated WNT gene expression is associated with high CUX1 and GLIS1 and with EMT gene signatures.","method":"Co-expression experiments, TCF/β-catenin reporter assays, cell migration and invasion assays, expression profiling","journal":"Biology open","confidence":"Medium","confidence_rationale":"Tier 2-3 — functional reporter assays and migration assays, single lab","pmids":["25217618"],"is_preprint":false},{"year":2011,"finding":"CUX1 acts as a negative regulator of TGF-β signaling-induced type I collagen transcription; CUX1 suppresses type I collagen through interference with gene transcription, and abnormal CUX1 expression is restored by TGF-β via the p38 MAPK pathway in fibroblasts.","method":"CUX1 overexpression/silencing in fibroblasts, in vivo fibrosis model, reporter/transcriptional interference assays, p38 inhibitor experiments","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2-3 — in vitro and in vivo convergent evidence with pathway inhibition, single lab","pmids":["21471005"],"is_preprint":false},{"year":2021,"finding":"CUX1 deficiency directly alleviates CUX1 repression of the CFLAR (FLIP) promoter, driving CFLAR expression and apoptosis evasion in AML; CFLAR is a selective vulnerability in CUX1-haploinsufficient AML identified by genome-wide CRISPR/Cas9 screening, and IAP antagonists exploit this vulnerability.","method":"Genome-wide CRISPR/Cas9 screen, promoter reporter assays, ChIP, murine and human AML models","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 — unbiased CRISPR screen plus ChIP and reporter assays confirming direct promoter repression","pmids":["33931647"],"is_preprint":false},{"year":2019,"finding":"p110 CUX1 (a transcription factor generated by proteolytic processing) promotes glycolytic gene expression (enolase 1, glucose-6-phosphate isomerase, phosphoglycerate kinase 1) in neuroblastoma; circ-CUX1 binds EWSR1 to facilitate EWSR1-MAZ interaction, resulting in transactivation of MAZ and CUX1 itself.","method":"Mechanistic RNA-protein binding assays, co-immunoprecipitation, inhibitory peptide blockade, lentiviral knockdown, metabolic assays","journal":"EMBO molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2-3 — CoIP and functional peptide blockade experiments, single lab","pmids":["31709724"],"is_preprint":false},{"year":2021,"finding":"A novel 113-aa protein (p113) encoded by the CUX1 circular RNA interacts with ZRF1 and BRD4 to form a transcriptional regulatory complex that upregulates ALDH3A1, NDUFA1, and NDUFAF5, driving lipid metabolic reprogramming and mitochondrial activity in neuroblastoma.","method":"Co-immunoprecipitation, mass spectrometry, ChIP sequencing, RNA sequencing, dual-luciferase reporter, inhibitory peptide blockade","journal":"Molecular cancer","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods (CoIP, MS, ChIP-seq, reporter) in a single lab","pmids":["34579723"],"is_preprint":false},{"year":2022,"finding":"CUX1 binds to an atherosclerosis-associated SNP (rs1537371) in the CDKN2A/B locus and regulates p14ARF, p15INK4b, p16INK4a, and ANRIL expression in endothelial cells; induction of CUX1 by DNA damage or oxidative stress triggers p16INK4a-dependent senescence.","method":"Post-GWAS functional SNP analysis, ChIP, CUX1 knockdown/overexpression, senescence assays","journal":"Nature aging","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP plus functional gain/loss-of-function experiments, single lab","pmids":["37117763"],"is_preprint":false},{"year":2004,"finding":"Cux-1 regulates the onset of joint formation by facilitating conversion of chondrocytes into nonchondrogenic interzone cells; retroviral Cux1 expression in micromass chondrocyte cultures causes loss of cartilage matrix and downregulation of cartilage-specific gene expression.","method":"Retroviral expression in micromass cultures, Alcian blue staining, gene expression analysis","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2-3 — functional gain-of-function with specific phenotypic and molecular readouts, single lab","pmids":["11846476"],"is_preprint":false},{"year":2004,"finding":"Cux-1 interacts with the Groucho homolog TLE-4 (a corepressor of Notch signaling) and is upregulated by constitutively active Notch 1 in renal epithelial cells, associated with reduction of p27, suggesting Cux-1 functions in the Notch signaling pathway.","method":"Coexpression analysis, activated Notch 1 cell line, co-immunoprecipitation (inferred), immunohistochemistry, RT-PCR","journal":"Developmental dynamics","confidence":"Low","confidence_rationale":"Tier 3 — coexpression and single cell line data, mechanistic interaction not fully characterized","pmids":["15499562"],"is_preprint":false},{"year":2008,"finding":"A deletion in the Cux1 cathepsin L processing site leads to accumulation of unprocessed Cux1, downregulation of p21/p27, and accelerated PKD progression in cpk mice; nuclear cathepsin L is reduced in human ADPKD cells and Pkd1 null kidneys, corresponding to increased Cux1 protein levels.","method":"Mouse genetic model (Cux1 mutant × cpk), Western blot, immunohistochemistry for proliferation/apoptosis/p21/p27, nuclear cathepsin L analysis in ADPKD cells","journal":"American journal of physiology. Renal physiology","confidence":"Medium","confidence_rationale":"Tier 2 — mechanistic link between cathepsin L processing site deletion and PKD phenotype supported by multiple analyses","pmids":["18829740"],"is_preprint":false},{"year":2020,"finding":"Nuclear cathepsin L proteolytically processes CDP/CUX to generate the p110 isoform, which stably binds to the VEGF-D promoter and promotes VEGF-D transcription, thereby driving angiogenesis in gastric cancer.","method":"Co-immunoprecipitation, dual-luciferase reporter assay, Western blot, tube formation, HUVEC migration, and CAM assays","journal":"Gastric cancer","confidence":"Medium","confidence_rationale":"Tier 2-3 — CoIP and reporter assays linking CUX1 processing to VEGF-D transcription and angiogenesis readouts","pmids":["32388635"],"is_preprint":false}],"current_model":"CUX1 is a multifunctional homeodomain transcription factor that exists as multiple isoforms (p200, p110, p90, p75, p113) generated by alternative transcription initiation, circular RNA translation, or nuclear cathepsin L-mediated proteolytic processing at the G1/S transition; the processed isoforms (especially p110) stably bind DNA, cooperate with E2F1/E2F2 to activate cell cycle genes, repress CDK inhibitors p21 and p27, and additionally serve as an ancillary factor in base excision repair by directly stimulating OGG1 glycosylase/AP-lyase and APE1 endonuclease activities through its CUT repeat domains, thereby accelerating S phase entry, enabling repair of oxidative DNA damage, preventing cellular senescence, and influencing diverse processes including dendritic morphogenesis, inflammatory gene regulation, and tumor suppression."},"narrative":{"teleology":[{"year":1999,"claim":"Establishing CUX1 as a transcriptional repressor that acts through direct DNA binding and protein–protein interactions: CUX1 was shown to repress the immunoglobulin heavy chain enhancer by competing with Bright at MAR sequences, and separately to bind SATB1 via its CUT repeats, mutually inhibiting DNA binding of both factors.","evidence":"EMSA, co-immunoprecipitation, reporter assays, GST pull-down, Far-Western in lymphoid cells","pmids":["9858552","10373541"],"confidence":"High","gaps":["Whether CUX1–SATB1 interaction is relevant in non-lymphoid contexts remains untested","No structural detail of CUT repeat–partner interfaces"]},{"year":2002,"claim":"Discovery of the p75 isoform established that CUX1 generates functionally distinct shorter proteins by alternative transcription initiation, capable of repressing p21 and activating DNA replication genes.","evidence":"RT-PCR mapping of intron 20 initiation site, reporter assays for p21 and DNA polymerase alpha promoters, mammary epithelial cell models","pmids":["12438259"],"confidence":"Medium","gaps":["Relative physiological abundance of p75 vs. other isoforms in normal tissues unclear","Mechanism distinguishing repression vs. activation by the same isoform not resolved"]},{"year":2004,"claim":"The mechanism generating the dominant CUX1 isoform p110 was resolved: a nuclear, signal-peptide-less cathepsin L is translated from alternative AUG sites, localizes to the nucleus specifically during G1/S, and proteolytically cleaves full-length CUX1.","evidence":"Activity-based probe labeling, cathepsin L knockout MEFs, immunofluorescence, ectopic expression rescue","pmids":["15099520"],"confidence":"High","gaps":["Signals controlling nuclear import of cathepsin L not defined","Whether other substrates of nuclear cathepsin L coordinate with CUX1 processing is unknown"]},{"year":2006,"claim":"The functional consequence of CUX1 processing was established: p110 accelerates S-phase entry by 2–4 hours, upregulates cyclins E2 and A2, and genetic inactivation (Cutl1z/z) prolongs G1 and reduces proliferation, defining CUX1 as a cell cycle accelerator.","evidence":"Stable p110 expression, multiple synchronization methods, centrifugal elutriation, Cutl1z/z MEFs, tumor growth assays","pmids":["16508018","16972798"],"confidence":"High","gaps":["Relative contributions of transcriptional activation vs. CDK inhibitor repression to G1 shortening not separated","Whether p90 has overlapping or distinct cell cycle roles vs. p110 not resolved"]},{"year":2008,"claim":"The transcriptional cooperation mechanism was defined: p110 physically interacts with E2F1/E2F2 and promotes their recruitment to target promoters containing low-affinity E2F sites, explaining how CUX1 activates DNA replication and cell cycle genes.","evidence":"Tandem affinity purification, co-immunoprecipitation, ChIP, linker-scanning mutagenesis, genome-wide location analysis","pmids":["18347061"],"confidence":"High","gaps":["Whether CUX1 modifies E2F chromatin environment (e.g., histone modifications) is not addressed","Selectivity for E2F1/E2F2 over other E2F family members not mechanistically explained"]},{"year":2009,"claim":"CUX1 was linked to repression of p27Kip1 through direct promoter binding with co-repressor Grg4 and HDAC1/3, and separately shown to confer anti-apoptotic activity via BCL2 upregulation downstream of PI3K/Akt and to regulate Wnt pathway genes.","evidence":"ChIP in kidney tissue, DNase I footprinting of p27 promoter, CoIP for Grg4/HDACs; Akt pathway modulation and xenograft models for apoptosis; ChIP and shRNA for Wnt targets","pmids":["19332113","20442202","19738070"],"confidence":"Medium","gaps":["Whether CUX1 directly recruits HDACs or requires Grg4 as obligate bridge is unclear","Independence of Wnt-regulatory and cell cycle roles not separated genetically"]},{"year":2010,"claim":"CUX1 was established as a regulator of neuronal morphogenesis: increasing CUX1 reduces dendritic complexity through p27 suppression and RhoA, while CUX1/CUX2 together control spine development and synapse formation in layer II–III cortical neurons.","evidence":"Knockout and knockdown mice, electrophysiology, morphological quantification, gain/loss-of-function in neuronal cultures","pmids":["20510857","20485671"],"confidence":"High","gaps":["Whether the BER function of CUX1 contributes to neuronal survival or morphogenesis is untested","Cell-type specificity of CUX1 vs. CUX2 functions in cortex not fully resolved"]},{"year":2014,"claim":"A transcription-independent role for CUX1 in DNA repair was uncovered: CUT repeat domains directly stimulate OGG1 glycosylase/AP-lyase activity in reconstituted base excision repair, and CUX1 haploinsufficiency impairs oxidative damage repair; CUX1 prevents RAS-induced senescence and is synthetic lethal with oncogenic RAS.","evidence":"In vitro BER with purified proteins, comet assay, Cux1+/− and Cux1−/− MEFs, RNAi synthetic lethality, transgenic mice","pmids":["24618719","25682875"],"confidence":"High","gaps":["Structural basis for CUT domain stimulation of OGG1 not determined","Whether CUX1 coordinates OGG1 and APE1 simultaneously or sequentially in vivo is unknown"]},{"year":2018,"claim":"The BER accessory role was extended to APE1 stimulation: CUT domains directly enhance APE1 endonuclease activity, and CUX1 knockdown increases genomic abasic sites, while CUX1 overexpression confers temozolomide resistance in glioblastoma.","evidence":"In vitro DNA repair assays with purified CUT domains, abasic site quantification, clonogenic survival in glioblastoma cells","pmids":["29036362"],"confidence":"High","gaps":["Whether CUX1 stimulates other BER enzymes (e.g., DNA polymerase β, ligase III) is untested","In vivo relevance of CUX1-mediated temozolomide resistance beyond cell lines not established"]},{"year":2021,"claim":"CUX1 haploinsufficiency in AML was mechanistically linked to de-repression of CFLAR (FLIP), establishing a direct tumor-suppressive circuit: CUX1 normally represses the CFLAR promoter, and its loss enables apoptosis evasion; a genome-wide CRISPR screen identified CFLAR as a selective vulnerability exploitable by IAP antagonists.","evidence":"Genome-wide CRISPR/Cas9 screen, ChIP, promoter reporter assays, murine and human AML models","pmids":["33931647"],"confidence":"High","gaps":["Whether CFLAR de-repression is the primary driver of CUX1-haploinsufficient AML or one of several effectors is unresolved","The co-repressor complex mediating CFLAR repression by CUX1 is not defined"]},{"year":2022,"claim":"CUX1 was connected to vascular aging by binding an atherosclerosis-associated SNP at the CDKN2A/B locus, regulating p16INK4a expression, and triggering senescence in endothelial cells upon oxidative or DNA damage stress.","evidence":"Post-GWAS SNP functional analysis, ChIP, CUX1 knockdown/overexpression, senescence assays in endothelial cells","pmids":["37117763"],"confidence":"Medium","gaps":["Whether CUX1 binding at rs1537371 is allele-specific in vivo is not fully resolved","Contribution of the BER function of CUX1 to the senescence phenotype at this locus is untested"]},{"year":null,"claim":"Key unresolved questions include the structural basis of CUT domain stimulation of BER enzymes, how isoform-specific functions are coordinated in vivo, and whether CUX1's transcriptional and DNA repair roles are integrated at sites of chromatin damage.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No crystal or cryo-EM structure of CUT domain bound to OGG1 or APE1","In vivo isoform-specific contributions during tissue homeostasis not separated by conditional genetics","Whether CUX1 transcriptional targets and BER function converge at replication-associated damage sites is unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[2,3,4,5,14,15,20]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[2,4,5,14,23]},{"term_id":"GO:0140097","term_label":"catalytic activity, acting on DNA","supporting_discovery_ids":[7,8,9]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[7,8,9]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,4,7,10,14]}],"pathway":[{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[0,3,4]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[7,8,9,10,11]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[2,4,5,14,15,20]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[16,20]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[17,18,19]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[12,13,24]}],"complexes":[],"partners":["E2F1","E2F2","OGG1","APE1","SATB1","TLE4","RELA","GLIS1"],"other_free_text":[]},"mechanistic_narrative":"CUX1 is a homeodomain transcription factor with dual roles in cell cycle regulation and DNA damage repair, operating through multiple isoforms generated by proteolytic processing, alternative transcription initiation, and circular RNA translation. Nuclear cathepsin L cleaves full-length CUX1 (p200) at the G1/S boundary to produce the p110 isoform, which stably binds DNA, cooperates with E2F1/E2F2 to activate S-phase genes (cyclin E2, cyclin A2, DNA polymerase alpha), and recruits co-repressors Groucho/TLE4 with HDAC1/3 to silence CDK inhibitors p21 and p27, thereby accelerating G1/S transit [PMID:15099520, PMID:16508018, PMID:18347061, PMID:19332113]. Independent of its transcriptional activity, CUX1 CUT repeat domains directly stimulate base excision repair enzymes OGG1 and APE1, enabling repair of oxidative DNA damage and preventing RAS-induced senescence; Cux1-null cells fail to proliferate under normoxic conditions but are rescued by a CUT-domain-only construct lacking transcriptional capacity [PMID:24618719, PMID:25682875, PMID:29036362]. CUX1 additionally regulates inflammatory chemokine expression through cooperation with NF-κB, controls dendritic branching in cortical neurons partly via p27 suppression, transcriptionally activates Wnt pathway genes, and functions as a haploinsufficient tumor suppressor whose loss in AML de-represses the anti-apoptotic gene CFLAR [PMID:32079724, PMID:20510857, PMID:19738070, PMID:33931647]."},"prefetch_data":{"uniprot":{"accession":"P39880","full_name":"Homeobox protein cut-like 1","aliases":["CCAAT displacement protein","CDP","CDP/Cux p200","Homeobox protein cux-1"],"length_aa":1505,"mass_kda":164.2,"function":"Transcription factor involved in the control of neuronal differentiation in the brain. Regulates dendrite development and branching, and dendritic spine formation in cortical layers II-III. Also involved in the control of synaptogenesis. In addition, it has probably a broad role in mammalian development as a repressor of developmentally regulated gene expression. May act by preventing binding of positively-activing CCAAT factors to promoters. Component of nf-munr repressor; binds to the matrix attachment regions (MARs) (5' and 3') of the immunoglobulin heavy chain enhancer. Represses T-cell receptor (TCR) beta enhancer function by binding to MARbeta, an ATC-rich DNA sequence located upstream of the TCR beta enhancer. Binds to the TH enhancer; may require the basic helix-loop-helix protein TCF4 as a coactivator Plays a role in cell cycle progression, in particular at the G1/S transition. As cells progress into S phase, a fraction of CUX1 molecules is proteolytically processed into N-terminally truncated proteins of 110 kDa. While CUX1 only transiently binds to DNA and carries the CCAAT-displacement activity, CDP/Cux p110 makes a stable interaction with DNA and stimulates expression of genes such as POLA1","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P39880/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CUX1","classification":"Not Classified","n_dependent_lines":6,"n_total_lines":1208,"dependency_fraction":0.004966887417218543},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"HDAC1","stoichiometry":0.2},{"gene":"RAB1A","stoichiometry":0.2},{"gene":"RAB1B","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/CUX1","total_profiled":1310},"omim":[{"mim_id":"619417","title":"TRIPARTITE MOTIF-CONTAINING PROTEIN 61; TRIM61","url":"https://www.omim.org/entry/619417"},{"mim_id":"618476","title":"BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS","url":"https://www.omim.org/entry/618476"},{"mim_id":"618330","title":"NEURODEVELOPMENTAL DISORDER WITH DEVELOPMENTAL DELAY AND WITH OR WITHOUT MOTOR OR SPEECH DELAY; NEDDMS","url":"https://www.omim.org/entry/618330"},{"mim_id":"617600","title":"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 45; MRD45","url":"https://www.omim.org/entry/617600"},{"mim_id":"612082","title":"CAPICUA TRANSCRIPTIONAL REPRESSOR; CIC","url":"https://www.omim.org/entry/612082"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Golgi apparatus","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/CUX1"},"hgnc":{"alias_symbol":["CDP","CDP1","CUX","CUT","Clox","CDP/Cut","CDP/Cux","Cux/CDP","CASP","GOLIM6"],"prev_symbol":["CUTL1"]},"alphafold":{"accession":"P39880","domains":[{"cath_id":"1.10.260.40","chopping":"554-630","consensus_level":"high","plddt":88.0858,"start":554,"end":630},{"cath_id":"1.10.260.40","chopping":"933-1008","consensus_level":"high","plddt":89.022,"start":933,"end":1008},{"cath_id":"1.10.260.40","chopping":"1116-1213","consensus_level":"medium","plddt":87.681,"start":1116,"end":1213},{"cath_id":"1.10.10.60","chopping":"1251-1309","consensus_level":"medium","plddt":87.29,"start":1251,"end":1309}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P39880","model_url":"https://alphafold.ebi.ac.uk/files/AF-P39880-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P39880-F1-predicted_aligned_error_v6.png","plddt_mean":61.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CUX1","jax_strain_url":"https://www.jax.org/strain/search?query=CUX1"},"sequence":{"accession":"P39880","fasta_url":"https://rest.uniprot.org/uniprotkb/P39880.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P39880/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P39880"}},"corpus_meta":[{"pmid":"31036827","id":"PMC_31036827","title":"CUT&Tag for efficient epigenomic profiling of small samples and single cells.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31036827","citation_count":1614,"is_preprint":false},{"pmid":"18809224","id":"PMC_18809224","title":"MMEJ repair of double-strand breaks (director's cut): deleted sequences and alternative endings.","date":"2008","source":"Trends in genetics : TIG","url":"https://pubmed.ncbi.nlm.nih.gov/18809224","citation_count":734,"is_preprint":false},{"pmid":"16129881","id":"PMC_16129881","title":"Regulating cell migration: calpains make the cut.","date":"2005","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/16129881","citation_count":394,"is_preprint":false},{"pmid":"31232687","id":"PMC_31232687","title":"Improved CUT&RUN chromatin profiling tools.","date":"2019","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/31232687","citation_count":374,"is_preprint":false},{"pmid":"33846645","id":"PMC_33846645","title":"Single-cell CUT&Tag profiles histone modifications and transcription factors in complex tissues.","date":"2021","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/33846645","citation_count":346,"is_preprint":false},{"pmid":"32913232","id":"PMC_32913232","title":"Efficient low-cost chromatin profiling with CUT&Tag.","date":"2020","source":"Nature protocols","url":"https://pubmed.ncbi.nlm.nih.gov/32913232","citation_count":313,"is_preprint":false},{"pmid":"15099520","id":"PMC_15099520","title":"A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factor.","date":"2004","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/15099520","citation_count":299,"is_preprint":false},{"pmid":"35143307","id":"PMC_35143307","title":"Spatial-CUT&Tag: Spatially resolved chromatin modification profiling at the cellular level.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35143307","citation_count":256,"is_preprint":false},{"pmid":"20510857","id":"PMC_20510857","title":"Cux1 and Cux2 regulate dendritic branching, spine morphology, and synapses of the upper layer neurons of the cortex.","date":"2010","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/20510857","citation_count":244,"is_preprint":false},{"pmid":"23010477","id":"PMC_23010477","title":"Phosphatidylcholine and the CDP-choline cycle.","date":"2012","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/23010477","citation_count":212,"is_preprint":false},{"pmid":"11403998","id":"PMC_11403998","title":"Role of the multifunctional CDP/Cut/Cux homeodomain transcription factor in regulating differentiation, cell growth and development.","date":"2001","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/11403998","citation_count":200,"is_preprint":false},{"pmid":"34792172","id":"PMC_34792172","title":"Genome-wide mapping of G-quadruplex structures with CUT&Tag.","date":"2022","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/34792172","citation_count":145,"is_preprint":false},{"pmid":"7869846","id":"PMC_7869846","title":"Metabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicoline.","date":"1995","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/7869846","citation_count":144,"is_preprint":false},{"pmid":"33846646","id":"PMC_33846646","title":"Single-cell CUT&Tag analysis of chromatin modifications in differentiation and tumor progression.","date":"2021","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/33846646","citation_count":142,"is_preprint":false},{"pmid":"31709724","id":"PMC_31709724","title":"Therapeutic targeting of circ-CUX1/EWSR1/MAZ axis inhibits glycolysis and neuroblastoma progression.","date":"2019","source":"EMBO molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31709724","citation_count":133,"is_preprint":false},{"pmid":"37316672","id":"PMC_37316672","title":"Genome editing of a rice CDP-DAG synthase confers multipathogen resistance.","date":"2023","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/37316672","citation_count":132,"is_preprint":false},{"pmid":"9695827","id":"PMC_9695827","title":"Fission yeast cut mutations revisited: control of anaphase.","date":"1998","source":"Trends in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/9695827","citation_count":132,"is_preprint":false},{"pmid":"23212519","id":"PMC_23212519","title":"CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia.","date":"2012","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/23212519","citation_count":128,"is_preprint":false},{"pmid":"18313863","id":"PMC_18313863","title":"The multiple roles of CUX1: insights from mouse models and cell-based assays.","date":"2008","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/18313863","citation_count":127,"is_preprint":false},{"pmid":"8709678","id":"PMC_8709678","title":"CDP-choline: pharmacological and clinical review.","date":"1995","source":"Methods and findings in experimental and clinical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/8709678","citation_count":121,"is_preprint":false},{"pmid":"16126385","id":"PMC_16126385","title":"Microtubules cut and run.","date":"2005","source":"Trends in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16126385","citation_count":118,"is_preprint":false},{"pmid":"31500663","id":"PMC_31500663","title":"CUT&RUNTools: a flexible pipeline for CUT&RUN processing and footprint analysis.","date":"2019","source":"Genome biology","url":"https://pubmed.ncbi.nlm.nih.gov/31500663","citation_count":103,"is_preprint":false},{"pmid":"8602527","id":"PMC_8602527","title":"Switching from cut-and-paste to replicative Tn7 transposition.","date":"1996","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/8602527","citation_count":102,"is_preprint":false},{"pmid":"36536148","id":"PMC_36536148","title":"Multimodal chromatin profiling using nanobody-based single-cell CUT&Tag.","date":"2022","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/36536148","citation_count":92,"is_preprint":false},{"pmid":"25190083","id":"PMC_25190083","title":"CUX1, a haploinsufficient tumour suppressor gene overexpressed in advanced cancers.","date":"2014","source":"Nature reviews. Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/25190083","citation_count":92,"is_preprint":false},{"pmid":"20442202","id":"PMC_20442202","title":"CUX1: target of Akt signalling and mediator of resistance to apoptosis in pancreatic cancer.","date":"2010","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/20442202","citation_count":87,"is_preprint":false},{"pmid":"17673461","id":"PMC_17673461","title":"The CDP-ethanolamine pathway and phosphatidylserine decarboxylation generate different phosphatidylethanolamine molecular species.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17673461","citation_count":87,"is_preprint":false},{"pmid":"11044454","id":"PMC_11044454","title":"Overexpression of a mammalian ethanolamine-specific kinase accelerates the CDP-ethanolamine pathway.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11044454","citation_count":86,"is_preprint":false},{"pmid":"19666474","id":"PMC_19666474","title":"Elimination of the CDP-ethanolamine pathway disrupts hepatic lipid homeostasis.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19666474","citation_count":85,"is_preprint":false},{"pmid":"32117988","id":"PMC_32117988","title":"CDP-Diacylglycerol Synthases (CDS): Gateway to Phosphatidylinositol and Cardiolipin Synthesis.","date":"2020","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/32117988","citation_count":84,"is_preprint":false},{"pmid":"2822695","id":"PMC_2822695","title":"Purification and characterization of CDP-diacylglycerol synthase from Saccharomyces cerevisiae.","date":"1987","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2822695","citation_count":75,"is_preprint":false},{"pmid":"32079724","id":"PMC_32079724","title":"CUX1 and IκBζ (NFKBIZ) mediate the synergistic inflammatory response to TNF and IL-17A in stromal fibroblasts.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/32079724","citation_count":73,"is_preprint":false},{"pmid":"28275684","id":"PMC_28275684","title":"Thymic Stromal Lymphopoietin: To Cut a Long Story Short.","date":"2017","source":"Cellular and molecular gastroenterology and hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/28275684","citation_count":68,"is_preprint":false},{"pmid":"9858552","id":"PMC_9858552","title":"Cux/CDP homeoprotein is a component of NF-muNR and represses the immunoglobulin heavy chain intronic enhancer by antagonizing the bright transcription activator.","date":"1999","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9858552","citation_count":68,"is_preprint":false},{"pmid":"27810282","id":"PMC_27810282","title":"The Abscission Checkpoint: Making It to the Final Cut.","date":"2016","source":"Trends in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/27810282","citation_count":67,"is_preprint":false},{"pmid":"22306263","id":"PMC_22306263","title":"CUX1 transcription factors: from biochemical activities and cell-based assays to mouse models and human diseases.","date":"2012","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/22306263","citation_count":65,"is_preprint":false},{"pmid":"9370321","id":"PMC_9370321","title":"CDP-choline:1,2-diacylglycerol cholinephosphotransferase.","date":"1997","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/9370321","citation_count":63,"is_preprint":false},{"pmid":"9083091","id":"PMC_9083091","title":"Gene cloning and characterization of CDP-diacylglycerol synthase from rat brain.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9083091","citation_count":61,"is_preprint":false},{"pmid":"12438259","id":"PMC_12438259","title":"Characterization of a tissue-specific CDP/Cux isoform, p75, activated in breast tumor cells.","date":"2002","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/12438259","citation_count":60,"is_preprint":false},{"pmid":"34579723","id":"PMC_34579723","title":"p113 isoform encoded by CUX1 circular RNA drives tumor progression via facilitating ZRF1/BRD4 transactivation.","date":"2021","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/34579723","citation_count":58,"is_preprint":false},{"pmid":"24618719","id":"PMC_24618719","title":"RAS transformation requires CUX1-dependent repair of oxidative DNA damage.","date":"2014","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/24618719","citation_count":57,"is_preprint":false},{"pmid":"16508018","id":"PMC_16508018","title":"The p110 isoform of the CDP/Cux transcription factor accelerates entry into S phase.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16508018","citation_count":57,"is_preprint":false},{"pmid":"20485671","id":"PMC_20485671","title":"The transcription factor Cux1 regulates dendritic morphology of cortical pyramidal neurons.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20485671","citation_count":52,"is_preprint":false},{"pmid":"22226841","id":"PMC_22226841","title":"CDP-choline treatment induces brain plasticity markers expression in experimental animal stroke.","date":"2011","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/22226841","citation_count":52,"is_preprint":false},{"pmid":"31671185","id":"PMC_31671185","title":"Making the cut(s): how Cas12a cleaves target and non-target DNA.","date":"2019","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/31671185","citation_count":51,"is_preprint":false},{"pmid":"25059644","id":"PMC_25059644","title":"Cux1 and Cux2 selectively target basal and apical dendritic compartments of layer II-III cortical neurons.","date":"2014","source":"Developmental neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/25059644","citation_count":50,"is_preprint":false},{"pmid":"32884577","id":"PMC_32884577","title":"Efficient chromatin profiling of H3K4me3 modification in cotton using CUT&Tag.","date":"2020","source":"Plant methods","url":"https://pubmed.ncbi.nlm.nih.gov/32884577","citation_count":47,"is_preprint":false},{"pmid":"18327765","id":"PMC_18327765","title":"Cux-1 and Cux-2 control the development of Reelin expressing cortical interneurons.","date":"2008","source":"Developmental neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/18327765","citation_count":45,"is_preprint":false},{"pmid":"15474416","id":"PMC_15474416","title":"Transcription and DNA adducts: what happens when the message gets cut off?","date":"2004","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/15474416","citation_count":45,"is_preprint":false},{"pmid":"22319212","id":"PMC_22319212","title":"CUX1 transcription factor is required for optimal ATM/ATR-mediated responses to DNA damage.","date":"2012","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/22319212","citation_count":44,"is_preprint":false},{"pmid":"16419078","id":"PMC_16419078","title":"Expression of Cux-1 and Cux-2 in the developing somatosensory cortex of normal and barrel-defective mice.","date":"2006","source":"The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology","url":"https://pubmed.ncbi.nlm.nih.gov/16419078","citation_count":44,"is_preprint":false},{"pmid":"10373541","id":"PMC_10373541","title":"Homeoproteins CDP and SATB1 interact: potential for tissue-specific regulation.","date":"1999","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10373541","citation_count":44,"is_preprint":false},{"pmid":"19738070","id":"PMC_19738070","title":"Mouse mammary tumor virus p75 and p110 CUX1 transgenic mice develop mammary tumors of various histologic types.","date":"2009","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/19738070","citation_count":42,"is_preprint":false},{"pmid":"24997421","id":"PMC_24997421","title":"Cysteine deleted protegrin-1 (CDP-1): anti-bacterial activity, outer-membrane disruption and selectivity.","date":"2014","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/24997421","citation_count":41,"is_preprint":false},{"pmid":"25217618","id":"PMC_25217618","title":"Autocrine Activation of the Wnt/β-Catenin Pathway by CUX1 and GLIS1 in Breast Cancers.","date":"2014","source":"Biology open","url":"https://pubmed.ncbi.nlm.nih.gov/25217618","citation_count":40,"is_preprint":false},{"pmid":"16023307","id":"PMC_16023307","title":"Isolation and characterization of murine Cds (CDP-diacylglycerol synthase) 1 and 2.","date":"2005","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/16023307","citation_count":40,"is_preprint":false},{"pmid":"9115637","id":"PMC_9115637","title":"Isolation and expression of an isoform of human CDP-diacylglycerol synthase cDNA.","date":"1997","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/9115637","citation_count":40,"is_preprint":false},{"pmid":"20689760","id":"PMC_20689760","title":"Glutamate receptor GRIA3--target of CUX1 and mediator of tumor progression in pancreatic cancer.","date":"2010","source":"Neoplasia (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/20689760","citation_count":39,"is_preprint":false},{"pmid":"18347061","id":"PMC_18347061","title":"p110 CUX1 cooperates with E2F transcription factors in the transcriptional activation of cell cycle-regulated genes.","date":"2008","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18347061","citation_count":37,"is_preprint":false},{"pmid":"31320321","id":"PMC_31320321","title":"Distinct clinical and biological implications of CUX1 in myeloid neoplasms.","date":"2019","source":"Blood advances","url":"https://pubmed.ncbi.nlm.nih.gov/31320321","citation_count":36,"is_preprint":false},{"pmid":"16972798","id":"PMC_16972798","title":"A novel proteolytically processed CDP/Cux isoform of 90 kDa is generated by cathepsin L.","date":"2006","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16972798","citation_count":36,"is_preprint":false},{"pmid":"34824276","id":"PMC_34824276","title":"AGPAT2 interaction with CDP-diacylglycerol synthases promotes the flux of fatty acids through the CDP-diacylglycerol pathway.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34824276","citation_count":35,"is_preprint":false},{"pmid":"11846476","id":"PMC_11846476","title":"Studies on the role of Cux1 in regulation of the onset of joint formation in the developing limb.","date":"2002","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/11846476","citation_count":35,"is_preprint":false},{"pmid":"24940603","id":"PMC_24940603","title":"New Clox Systems for rapid and efficient gene disruption in Candida albicans.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24940603","citation_count":34,"is_preprint":false},{"pmid":"32400008","id":"PMC_32400008","title":"Chiral Cux Coy S Nanoparticles under Magnetic Field and NIR Light to Eliminate Senescent Cells.","date":"2020","source":"Angewandte Chemie (International ed. in English)","url":"https://pubmed.ncbi.nlm.nih.gov/32400008","citation_count":34,"is_preprint":false},{"pmid":"12115525","id":"PMC_12115525","title":"Expression of N-terminally truncated isoforms of CDP/CUX is increased in human uterine leiomyomas.","date":"2002","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/12115525","citation_count":33,"is_preprint":false},{"pmid":"32388635","id":"PMC_32388635","title":"Cathepsin L promotes angiogenesis by regulating the CDP/Cux/VEGF-D pathway in human gastric cancer.","date":"2020","source":"Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association","url":"https://pubmed.ncbi.nlm.nih.gov/32388635","citation_count":32,"is_preprint":false},{"pmid":"14756787","id":"PMC_14756787","title":"A CDP-choline pathway for phosphatidylcholine biosynthesis in Treponema denticola.","date":"2004","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/14756787","citation_count":32,"is_preprint":false},{"pmid":"31548309","id":"PMC_31548309","title":"CDP-DAG synthase 1 and 2 regulate lipid droplet growth through distinct mechanisms.","date":"2019","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31548309","citation_count":32,"is_preprint":false},{"pmid":"9370323","id":"PMC_9370323","title":"CDP-ethanolamine:1,2-diacylglycerol ethanolaminephosphotransferase.","date":"1997","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/9370323","citation_count":31,"is_preprint":false},{"pmid":"21471005","id":"PMC_21471005","title":"High doses of TGF-β potently suppress type I collagen via the transcription factor CUX1.","date":"2011","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/21471005","citation_count":31,"is_preprint":false},{"pmid":"34921772","id":"PMC_34921772","title":"Making the cut with protease engineering.","date":"2021","source":"Cell chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/34921772","citation_count":30,"is_preprint":false},{"pmid":"15499562","id":"PMC_15499562","title":"Coexpression of Cux-1 and Notch signaling pathway components during kidney development.","date":"2004","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/15499562","citation_count":30,"is_preprint":false},{"pmid":"9045875","id":"PMC_9045875","title":"Antisense oligonucleotides to Cux-1, a Cut-related homeobox gene, cause increased apoptosis in mouse embryonic kidney cultures.","date":"1997","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/9045875","citation_count":29,"is_preprint":false},{"pmid":"32547943","id":"PMC_32547943","title":"CUX1, A Controversial Player in Tumor Development.","date":"2020","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/32547943","citation_count":29,"is_preprint":false},{"pmid":"18829740","id":"PMC_18829740","title":"Acceleration of polycystic kidney disease progression in cpk mice carrying a deletion in the homeodomain protein Cux1.","date":"2008","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/18829740","citation_count":29,"is_preprint":false},{"pmid":"19332113","id":"PMC_19332113","title":"The homeodomain protein Cux1 interacts with Grg4 to repress p27 kip1 expression during kidney development.","date":"2009","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/19332113","citation_count":28,"is_preprint":false},{"pmid":"33931647","id":"PMC_33931647","title":"Cut-like homeobox 1 (CUX1) tumor suppressor gene haploinsufficiency induces apoptosis evasion to sustain myeloid leukemia.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33931647","citation_count":27,"is_preprint":false},{"pmid":"36687696","id":"PMC_36687696","title":"Phosphatidylethanolamine homeostasis under conditions of impaired CDP-ethanolamine pathway or phosphatidylserine decarboxylation.","date":"2023","source":"Frontiers in nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/36687696","citation_count":27,"is_preprint":false},{"pmid":"29518378","id":"PMC_29518378","title":"The crux of Cux genes in neuronal function and plasticity.","date":"2018","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/29518378","citation_count":26,"is_preprint":false},{"pmid":"30010043","id":"PMC_30010043","title":"CUX1-ALK, a Novel ALK Rearrangement That Responds to Crizotinib in Non-Small Cell Lung Cancer.","date":"2018","source":"Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/30010043","citation_count":26,"is_preprint":false},{"pmid":"28147323","id":"PMC_28147323","title":"The DNA repair function of CUX1 contributes to radioresistance.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28147323","citation_count":25,"is_preprint":false},{"pmid":"29671584","id":"PMC_29671584","title":"Tailored Polyproteins Using Sequential Staple and Cut.","date":"2018","source":"Bioconjugate chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29671584","citation_count":25,"is_preprint":false},{"pmid":"25682875","id":"PMC_25682875","title":"The function of CUX1 in oxidative DNA damage repair is needed to prevent premature senescence of mouse embryo fibroblasts.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/25682875","citation_count":25,"is_preprint":false},{"pmid":"27125999","id":"PMC_27125999","title":"Drosha and Dicer: Slicers cut from the same cloth.","date":"2016","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/27125999","citation_count":25,"is_preprint":false},{"pmid":"38105608","id":"PMC_38105608","title":"Cut&tag: a powerful epigenetic tool for chromatin profiling.","date":"2023","source":"Epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/38105608","citation_count":24,"is_preprint":false},{"pmid":"36725417","id":"PMC_36725417","title":"Gene editing for dyslipidemias: New tools to \"cut\" lipids.","date":"2023","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/36725417","citation_count":24,"is_preprint":false},{"pmid":"29036362","id":"PMC_29036362","title":"CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent temozolomide.","date":"2018","source":"Neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/29036362","citation_count":24,"is_preprint":false},{"pmid":"12631340","id":"PMC_12631340","title":"Cux-1 transgenic mice develop glomerulosclerosis and interstitial fibrosis.","date":"2003","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/12631340","citation_count":24,"is_preprint":false},{"pmid":"33912205","id":"PMC_33912205","title":"Rapid and Low-Input Profiling of Histone Marks in Plants Using Nucleus CUT&Tag.","date":"2021","source":"Frontiers in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/33912205","citation_count":24,"is_preprint":false},{"pmid":"23590133","id":"PMC_23590133","title":"Long-range transcriptional regulation by the p110 CUX1 homeodomain protein on the ENCODE array.","date":"2013","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/23590133","citation_count":23,"is_preprint":false},{"pmid":"19895633","id":"PMC_19895633","title":"Moyamoya: to cut or not to cut is not the only question. A paediatric neurologist's perspective.","date":"2009","source":"Developmental medicine and child neurology","url":"https://pubmed.ncbi.nlm.nih.gov/19895633","citation_count":21,"is_preprint":false},{"pmid":"34647658","id":"PMC_34647658","title":"Identification of chromatin states during zebrafish gastrulation using CUT&RUN and CUT&Tag.","date":"2021","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/34647658","citation_count":21,"is_preprint":false},{"pmid":"37117763","id":"PMC_37117763","title":"Post-GWAS functional analysis identifies CUX1 as a regulator of p16INK4a and cellular senescence.","date":"2022","source":"Nature aging","url":"https://pubmed.ncbi.nlm.nih.gov/37117763","citation_count":21,"is_preprint":false},{"pmid":"15812824","id":"PMC_15812824","title":"Hepatomegaly in transgenic mice expressing the homeobox gene Cux-1.","date":"2005","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/15812824","citation_count":21,"is_preprint":false},{"pmid":"37739938","id":"PMC_37739938","title":"Epigenomic analysis of formalin-fixed paraffin-embedded samples by CUT&Tag.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37739938","citation_count":20,"is_preprint":false},{"pmid":"23130995","id":"PMC_23130995","title":"Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases.","date":"2012","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23130995","citation_count":19,"is_preprint":false},{"pmid":"32194660","id":"PMC_32194660","title":"THBS2, a microRNA-744-5p target, modulates MMP9 expression through CUX1 in pancreatic neuroendocrine tumors.","date":"2020","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/32194660","citation_count":19,"is_preprint":false},{"pmid":"35416745","id":"PMC_35416745","title":"Chemical inhibition of polyphenol oxidase and cut surface browning of fresh-cut apples.","date":"2022","source":"Critical reviews in food science and nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/35416745","citation_count":18,"is_preprint":false},{"pmid":"21496637","id":"PMC_21496637","title":"FEN nucleases: bind, bend, fray, cut.","date":"2011","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/21496637","citation_count":18,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":44895,"output_tokens":6325,"usd":0.11478},"stage2":{"model":"claude-opus-4-6","input_tokens":10000,"output_tokens":3575,"usd":0.209063},"total_usd":0.323843,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"A nuclear isoform of cathepsin L, devoid of a signal peptide (translated from downstream AUG sites), localizes to the nucleus during the G1-S transition and proteolytically processes the CDP/CUX transcription factor to generate the p110 isoform, thereby regulating cell cycle progression.\",\n      \"method\": \"Immunofluorescence imaging, activity-based probe labeling, ectopic expression of cathepsin L, Cat L-/- cell analysis, in situ processing assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (imaging, genetic KO, activity-based probes, ectopic expression) in a single rigorous study\",\n      \"pmids\": [\"15099520\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"A 90 kDa CUX1 isoform (p90) is generated by cathepsin L proteolytic processing; its steady-state level correlates with cathepsin L activity, and it shares similar DNA-binding and transcriptional activities with p110.\",\n      \"method\": \"Deletion mapping, Western blot, co-expression with cathepsin L mutants\",\n      \"journal\": \"Biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — mapping and biochemical assays in a single lab, multiple constructs tested\",\n      \"pmids\": [\"16972798\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"A shorter CUX1 isoform, p75, is generated by transcription initiation within intron 20 and contains only Cut repeat 3 and the Cut homeodomain; it can repress the p21 promoter and activate a DNA polymerase alpha reporter, and its aberrant expression in mammary epithelial cells is associated with altered differentiation.\",\n      \"method\": \"Reporter assays, stable cell expression, RT-PCR, cell morphology/collagen assays\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — multiple functional assays, single lab\",\n      \"pmids\": [\"12438259\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The p110 CDP/CUX isoform accelerates entry into S phase by shortening G1 by 2-4 hours; it upregulates cyclin E2 and A2, and its loss in Cutl1z/z MEFs prolongs G1 and reduces proliferation.\",\n      \"method\": \"Stable cell populations with p110, synchronization experiments (growth factor deprivation, thymidine block, centrifugal elutriation), MEF genetic inactivation, focus formation and tumor growth assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple synchronization paradigms plus genetic KO with consistent phenotypic readouts\",\n      \"pmids\": [\"16508018\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"p110 CUX1 cooperates with E2F1 and E2F2 in transcriptional activation of cell cycle genes including DNA polymerase alpha; p110 engages in protein-protein interactions with E2F1/E2F2, promotes their recruitment to target promoters, and a low-affinity E2F binding site is required for this activation.\",\n      \"method\": \"Tandem affinity purification, co-immunoprecipitation, chromatin immunoprecipitation, linker-scanning analysis, reporter assays, genome-wide location analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — TAP, CoIP, ChIP, and reporter assays with multiple orthogonal methods in a single study\",\n      \"pmids\": [\"18347061\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"CUX1/CDP is a component of NF-μNR and represses the immunoglobulin heavy chain intronic enhancer (Eμ) by binding to MAR sequences and antagonizing the Bright transcription activator at both the DNA-binding and functional levels.\",\n      \"method\": \"Expression library screening, EMSA, co-immunoprecipitation, antiserum recognition, cotransfection/reporter assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (EMSA, CoIP, reporter assays) consistently demonstrating mechanism\",\n      \"pmids\": [\"9858552\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"CUX1/CDP interacts with SATB1 through its Cut repeats (CR1, CR2, and homeodomain); this interaction prevents each protein from binding DNA and CUX1 overexpression in T cells neutralizes SATB1-mediated repression of the MMTV promoter.\",\n      \"method\": \"GST pull-down, co-immunoprecipitation with specific antisera, Far-Western blot, gel retardation assay, reporter assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal in vitro and cell-based methods\",\n      \"pmids\": [\"10373541\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CUX1 functions as an ancillary factor in base excision repair by directly stimulating the enzymatic activity of 8-oxoG-DNA glycosylase OGG1; Cux1+/- MEFs are haploinsufficient for repair of oxidative DNA damage, whereas elevated CUX1 accelerates repair. CUX1 prevents RAS-induced senescence and is synthetic lethal with oncogenic RAS.\",\n      \"method\": \"In vitro BER assay with purified proteins, single-cell gel electrophoresis (comet assay), MEF haploinsufficiency analysis, RNAi synthetic lethality, transgenic mouse models\",\n      \"journal\": \"PLoS biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro BER assay with purified components plus multiple genetic and cellular validations\",\n      \"pmids\": [\"24618719\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"A single CUT repeat domain of CUX1 is sufficient to stimulate DNA binding, Schiff-base formation, glycosylase, and AP-lyase activities of OGG1; Cux1-/- MEFs cannot proliferate in 20% O2 but proliferate normally in 3% O2, rescued by ectopic CUX1 or a recombinant Cut repeat protein devoid of transcriptional activity.\",\n      \"method\": \"In vitro enzymatic assays with purified proteins, genetic rescue with structure-function constructs, MEF proliferation assays under different oxygen levels\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with purified domains plus structure-function analysis and genetic rescue\",\n      \"pmids\": [\"25682875\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CUX1 CUT domains stimulate APE1 (apurinic/apyrimidinic endonuclease 1) enzymatic activity; CUX1 knockdown increases abasic sites and decreases APE1 activity in cell extracts, while CUX1 overexpression or a two-CUT-domain protein increases APE1 activity and resistance of glioblastoma cells to temozolomide.\",\n      \"method\": \"In vitro DNA repair assay with purified proteins, abasic site quantification in genomic DNA, cell extract APE1 activity assay, clonogenic survival with CUX1 KD/OE\",\n      \"journal\": \"Neuro-oncology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro reconstitution with purified CUT domains plus concordant cell-based functional assays\",\n      \"pmids\": [\"29036362\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"CUX1 is rapidly recruited to sites of DNA damage; a recombinant protein containing only two CUT domains is sufficient for this recruitment, accelerates DNA repair, and increases clonogenic survival following ionizing radiation.\",\n      \"method\": \"Clonogenic survival assay, CUX1 KD/OE, recombinant CUT domain protein rescue, DNA damage focus analysis\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — structure-function with recombinant proteins plus cellular assays, single lab\",\n      \"pmids\": [\"28147323\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"CUX1 regulates the constitutive expression of ATM and ATR and genes involved in damage-induced signaling through them; CUX1 knockdown or genetic inactivation reduces ATM autophosphorylation, phospho-Chk2, p53 levels, γ-H2AX/Rad51 foci, and compromises DNA strand break repair and cell cycle checkpoints.\",\n      \"method\": \"RNAi knockdown, genetic inactivation, immunofluorescence for DNA damage foci, phosphoprotein analysis, genome-wide expression profiling\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide approach plus multiple functional readouts, single lab\",\n      \"pmids\": [\"22319212\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"CUX1 and CUX2 are intrinsic and complementary regulators of dendrite branching, spine development, and synapse formation in layer II-III cortical neurons; Cux genes control dendritic spine number and maturation partly through direct regulation of Xlr3b and Xlr4b expression, and Cux2-/- mice show reduced synaptic function and working memory defects.\",\n      \"method\": \"Knockout and knockdown mice, morphological, molecular, and electrophysiological analysis\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO combined with morphological, molecular, and electrophysiological readouts across multiple labs/publications\",\n      \"pmids\": [\"20510857\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Increasing Cux1 (but not Cux2) expression reduces dendritic complexity of cortical pyramidal neurons, while reducing Cux1 promotes dendritic arborization; this effect requires the DNA-binding domains and acts primarily through suppression of p27Kip1, with RhoA as a downstream mediator.\",\n      \"method\": \"In vitro neuronal cultures with gain/loss of function, immunofluorescence for dendritic morphology, signaling pathway analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — gain and loss of function with pathway analysis, single lab\",\n      \"pmids\": [\"20485671\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Cux1 directly interacts with the co-repressor Grg4 (Groucho 4) to enhance repression of p27Kip1; both Cux1 and Grg4 (along with HDAC1 and HDAC3) are recruited to the p27Kip1 promoter in vivo, and Cux1 binds directly to the p27Kip1 promoter at two sites identified by DNase I footprinting.\",\n      \"method\": \"Co-immunoprecipitation, promoter luciferase assay, ChIP in kidney tissue, DNase I footprinting\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including in vivo ChIP and in vitro footprinting confirming direct binding\",\n      \"pmids\": [\"19332113\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CUX1 mediates the synergistic inflammatory response to TNF and IL-17A in synovial fibroblasts by binding a unique CUX1-NF-κB motif in the promoters of CXCL1, CXCL2, and CXCL3 and cooperating with NF-κB p65 to drive their transcription, independent of LIFR, STAT3, STAT4, and ELF3.\",\n      \"method\": \"Gene silencing transcriptomics, siRNA knockdown, promoter motif analysis, functional reporter assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — multiple gene-silencing experiments with defined transcriptional readouts, single lab\",\n      \"pmids\": [\"32079724\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CUX1 expression is induced by PI3K/Akt signaling and decreased by PI3K inhibitors; CUX1 exerts anti-apoptotic activity by upregulating BCL2 and downregulating TNFα, conferring resistance to TRAIL- and drug-induced apoptosis in pancreatic cancer cells.\",\n      \"method\": \"CUX1 overexpression and knockdown, Akt pathway activation/inhibition, caspase activity assays, PARP cleavage, xenograft model with siRNA nanoparticles\",\n      \"journal\": \"Gut\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — multiple functional assays with both gain and loss of function, single lab\",\n      \"pmids\": [\"20442202\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CUX1 regulates several Wnt genes and is involved in establishing a Wnt/β-catenin autocrine loop in mammary tumors; CUX1 transcriptionally regulates Wnt genes as demonstrated by ChIP, shRNA-mediated knockdown, and reporter assays.\",\n      \"method\": \"Chromatin immunoprecipitation, shRNA knockdown, reporter assays, transgenic mouse mammary tumor analysis\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP, functional knockdown, and reporter assays, single lab\",\n      \"pmids\": [\"19738070\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CUX1 and GLIS1 cooperate to stimulate TCF/β-catenin transcriptional activity and enhance cell migration and invasion; elevated WNT gene expression is associated with high CUX1 and GLIS1 and with EMT gene signatures.\",\n      \"method\": \"Co-expression experiments, TCF/β-catenin reporter assays, cell migration and invasion assays, expression profiling\",\n      \"journal\": \"Biology open\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — functional reporter assays and migration assays, single lab\",\n      \"pmids\": [\"25217618\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CUX1 acts as a negative regulator of TGF-β signaling-induced type I collagen transcription; CUX1 suppresses type I collagen through interference with gene transcription, and abnormal CUX1 expression is restored by TGF-β via the p38 MAPK pathway in fibroblasts.\",\n      \"method\": \"CUX1 overexpression/silencing in fibroblasts, in vivo fibrosis model, reporter/transcriptional interference assays, p38 inhibitor experiments\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — in vitro and in vivo convergent evidence with pathway inhibition, single lab\",\n      \"pmids\": [\"21471005\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CUX1 deficiency directly alleviates CUX1 repression of the CFLAR (FLIP) promoter, driving CFLAR expression and apoptosis evasion in AML; CFLAR is a selective vulnerability in CUX1-haploinsufficient AML identified by genome-wide CRISPR/Cas9 screening, and IAP antagonists exploit this vulnerability.\",\n      \"method\": \"Genome-wide CRISPR/Cas9 screen, promoter reporter assays, ChIP, murine and human AML models\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — unbiased CRISPR screen plus ChIP and reporter assays confirming direct promoter repression\",\n      \"pmids\": [\"33931647\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"p110 CUX1 (a transcription factor generated by proteolytic processing) promotes glycolytic gene expression (enolase 1, glucose-6-phosphate isomerase, phosphoglycerate kinase 1) in neuroblastoma; circ-CUX1 binds EWSR1 to facilitate EWSR1-MAZ interaction, resulting in transactivation of MAZ and CUX1 itself.\",\n      \"method\": \"Mechanistic RNA-protein binding assays, co-immunoprecipitation, inhibitory peptide blockade, lentiviral knockdown, metabolic assays\",\n      \"journal\": \"EMBO molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — CoIP and functional peptide blockade experiments, single lab\",\n      \"pmids\": [\"31709724\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"A novel 113-aa protein (p113) encoded by the CUX1 circular RNA interacts with ZRF1 and BRD4 to form a transcriptional regulatory complex that upregulates ALDH3A1, NDUFA1, and NDUFAF5, driving lipid metabolic reprogramming and mitochondrial activity in neuroblastoma.\",\n      \"method\": \"Co-immunoprecipitation, mass spectrometry, ChIP sequencing, RNA sequencing, dual-luciferase reporter, inhibitory peptide blockade\",\n      \"journal\": \"Molecular cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (CoIP, MS, ChIP-seq, reporter) in a single lab\",\n      \"pmids\": [\"34579723\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"CUX1 binds to an atherosclerosis-associated SNP (rs1537371) in the CDKN2A/B locus and regulates p14ARF, p15INK4b, p16INK4a, and ANRIL expression in endothelial cells; induction of CUX1 by DNA damage or oxidative stress triggers p16INK4a-dependent senescence.\",\n      \"method\": \"Post-GWAS functional SNP analysis, ChIP, CUX1 knockdown/overexpression, senescence assays\",\n      \"journal\": \"Nature aging\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP plus functional gain/loss-of-function experiments, single lab\",\n      \"pmids\": [\"37117763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Cux-1 regulates the onset of joint formation by facilitating conversion of chondrocytes into nonchondrogenic interzone cells; retroviral Cux1 expression in micromass chondrocyte cultures causes loss of cartilage matrix and downregulation of cartilage-specific gene expression.\",\n      \"method\": \"Retroviral expression in micromass cultures, Alcian blue staining, gene expression analysis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — functional gain-of-function with specific phenotypic and molecular readouts, single lab\",\n      \"pmids\": [\"11846476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Cux-1 interacts with the Groucho homolog TLE-4 (a corepressor of Notch signaling) and is upregulated by constitutively active Notch 1 in renal epithelial cells, associated with reduction of p27, suggesting Cux-1 functions in the Notch signaling pathway.\",\n      \"method\": \"Coexpression analysis, activated Notch 1 cell line, co-immunoprecipitation (inferred), immunohistochemistry, RT-PCR\",\n      \"journal\": \"Developmental dynamics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — coexpression and single cell line data, mechanistic interaction not fully characterized\",\n      \"pmids\": [\"15499562\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"A deletion in the Cux1 cathepsin L processing site leads to accumulation of unprocessed Cux1, downregulation of p21/p27, and accelerated PKD progression in cpk mice; nuclear cathepsin L is reduced in human ADPKD cells and Pkd1 null kidneys, corresponding to increased Cux1 protein levels.\",\n      \"method\": \"Mouse genetic model (Cux1 mutant × cpk), Western blot, immunohistochemistry for proliferation/apoptosis/p21/p27, nuclear cathepsin L analysis in ADPKD cells\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic link between cathepsin L processing site deletion and PKD phenotype supported by multiple analyses\",\n      \"pmids\": [\"18829740\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Nuclear cathepsin L proteolytically processes CDP/CUX to generate the p110 isoform, which stably binds to the VEGF-D promoter and promotes VEGF-D transcription, thereby driving angiogenesis in gastric cancer.\",\n      \"method\": \"Co-immunoprecipitation, dual-luciferase reporter assay, Western blot, tube formation, HUVEC migration, and CAM assays\",\n      \"journal\": \"Gastric cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — CoIP and reporter assays linking CUX1 processing to VEGF-D transcription and angiogenesis readouts\",\n      \"pmids\": [\"32388635\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CUX1 is a multifunctional homeodomain transcription factor that exists as multiple isoforms (p200, p110, p90, p75, p113) generated by alternative transcription initiation, circular RNA translation, or nuclear cathepsin L-mediated proteolytic processing at the G1/S transition; the processed isoforms (especially p110) stably bind DNA, cooperate with E2F1/E2F2 to activate cell cycle genes, repress CDK inhibitors p21 and p27, and additionally serve as an ancillary factor in base excision repair by directly stimulating OGG1 glycosylase/AP-lyase and APE1 endonuclease activities through its CUT repeat domains, thereby accelerating S phase entry, enabling repair of oxidative DNA damage, preventing cellular senescence, and influencing diverse processes including dendritic morphogenesis, inflammatory gene regulation, and tumor suppression.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CUX1 is a homeodomain transcription factor with dual roles in cell cycle regulation and DNA damage repair, operating through multiple isoforms generated by proteolytic processing, alternative transcription initiation, and circular RNA translation. Nuclear cathepsin L cleaves full-length CUX1 (p200) at the G1/S boundary to produce the p110 isoform, which stably binds DNA, cooperates with E2F1/E2F2 to activate S-phase genes (cyclin E2, cyclin A2, DNA polymerase alpha), and recruits co-repressors Groucho/TLE4 with HDAC1/3 to silence CDK inhibitors p21 and p27, thereby accelerating G1/S transit [PMID:15099520, PMID:16508018, PMID:18347061, PMID:19332113]. Independent of its transcriptional activity, CUX1 CUT repeat domains directly stimulate base excision repair enzymes OGG1 and APE1, enabling repair of oxidative DNA damage and preventing RAS-induced senescence; Cux1-null cells fail to proliferate under normoxic conditions but are rescued by a CUT-domain-only construct lacking transcriptional capacity [PMID:24618719, PMID:25682875, PMID:29036362]. CUX1 additionally regulates inflammatory chemokine expression through cooperation with NF-κB, controls dendritic branching in cortical neurons partly via p27 suppression, transcriptionally activates Wnt pathway genes, and functions as a haploinsufficient tumor suppressor whose loss in AML de-represses the anti-apoptotic gene CFLAR [PMID:32079724, PMID:20510857, PMID:19738070, PMID:33931647].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Establishing CUX1 as a transcriptional repressor that acts through direct DNA binding and protein–protein interactions: CUX1 was shown to repress the immunoglobulin heavy chain enhancer by competing with Bright at MAR sequences, and separately to bind SATB1 via its CUT repeats, mutually inhibiting DNA binding of both factors.\",\n      \"evidence\": \"EMSA, co-immunoprecipitation, reporter assays, GST pull-down, Far-Western in lymphoid cells\",\n      \"pmids\": [\"9858552\", \"10373541\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether CUX1–SATB1 interaction is relevant in non-lymphoid contexts remains untested\",\n        \"No structural detail of CUT repeat–partner interfaces\"\n      ]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Discovery of the p75 isoform established that CUX1 generates functionally distinct shorter proteins by alternative transcription initiation, capable of repressing p21 and activating DNA replication genes.\",\n      \"evidence\": \"RT-PCR mapping of intron 20 initiation site, reporter assays for p21 and DNA polymerase alpha promoters, mammary epithelial cell models\",\n      \"pmids\": [\"12438259\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Relative physiological abundance of p75 vs. other isoforms in normal tissues unclear\",\n        \"Mechanism distinguishing repression vs. activation by the same isoform not resolved\"\n      ]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"The mechanism generating the dominant CUX1 isoform p110 was resolved: a nuclear, signal-peptide-less cathepsin L is translated from alternative AUG sites, localizes to the nucleus specifically during G1/S, and proteolytically cleaves full-length CUX1.\",\n      \"evidence\": \"Activity-based probe labeling, cathepsin L knockout MEFs, immunofluorescence, ectopic expression rescue\",\n      \"pmids\": [\"15099520\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Signals controlling nuclear import of cathepsin L not defined\",\n        \"Whether other substrates of nuclear cathepsin L coordinate with CUX1 processing is unknown\"\n      ]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"The functional consequence of CUX1 processing was established: p110 accelerates S-phase entry by 2–4 hours, upregulates cyclins E2 and A2, and genetic inactivation (Cutl1z/z) prolongs G1 and reduces proliferation, defining CUX1 as a cell cycle accelerator.\",\n      \"evidence\": \"Stable p110 expression, multiple synchronization methods, centrifugal elutriation, Cutl1z/z MEFs, tumor growth assays\",\n      \"pmids\": [\"16508018\", \"16972798\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Relative contributions of transcriptional activation vs. CDK inhibitor repression to G1 shortening not separated\",\n        \"Whether p90 has overlapping or distinct cell cycle roles vs. p110 not resolved\"\n      ]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"The transcriptional cooperation mechanism was defined: p110 physically interacts with E2F1/E2F2 and promotes their recruitment to target promoters containing low-affinity E2F sites, explaining how CUX1 activates DNA replication and cell cycle genes.\",\n      \"evidence\": \"Tandem affinity purification, co-immunoprecipitation, ChIP, linker-scanning mutagenesis, genome-wide location analysis\",\n      \"pmids\": [\"18347061\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether CUX1 modifies E2F chromatin environment (e.g., histone modifications) is not addressed\",\n        \"Selectivity for E2F1/E2F2 over other E2F family members not mechanistically explained\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"CUX1 was linked to repression of p27Kip1 through direct promoter binding with co-repressor Grg4 and HDAC1/3, and separately shown to confer anti-apoptotic activity via BCL2 upregulation downstream of PI3K/Akt and to regulate Wnt pathway genes.\",\n      \"evidence\": \"ChIP in kidney tissue, DNase I footprinting of p27 promoter, CoIP for Grg4/HDACs; Akt pathway modulation and xenograft models for apoptosis; ChIP and shRNA for Wnt targets\",\n      \"pmids\": [\"19332113\", \"20442202\", \"19738070\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether CUX1 directly recruits HDACs or requires Grg4 as obligate bridge is unclear\",\n        \"Independence of Wnt-regulatory and cell cycle roles not separated genetically\"\n      ]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"CUX1 was established as a regulator of neuronal morphogenesis: increasing CUX1 reduces dendritic complexity through p27 suppression and RhoA, while CUX1/CUX2 together control spine development and synapse formation in layer II–III cortical neurons.\",\n      \"evidence\": \"Knockout and knockdown mice, electrophysiology, morphological quantification, gain/loss-of-function in neuronal cultures\",\n      \"pmids\": [\"20510857\", \"20485671\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the BER function of CUX1 contributes to neuronal survival or morphogenesis is untested\",\n        \"Cell-type specificity of CUX1 vs. CUX2 functions in cortex not fully resolved\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"A transcription-independent role for CUX1 in DNA repair was uncovered: CUT repeat domains directly stimulate OGG1 glycosylase/AP-lyase activity in reconstituted base excision repair, and CUX1 haploinsufficiency impairs oxidative damage repair; CUX1 prevents RAS-induced senescence and is synthetic lethal with oncogenic RAS.\",\n      \"evidence\": \"In vitro BER with purified proteins, comet assay, Cux1+/− and Cux1−/− MEFs, RNAi synthetic lethality, transgenic mice\",\n      \"pmids\": [\"24618719\", \"25682875\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis for CUT domain stimulation of OGG1 not determined\",\n        \"Whether CUX1 coordinates OGG1 and APE1 simultaneously or sequentially in vivo is unknown\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"The BER accessory role was extended to APE1 stimulation: CUT domains directly enhance APE1 endonuclease activity, and CUX1 knockdown increases genomic abasic sites, while CUX1 overexpression confers temozolomide resistance in glioblastoma.\",\n      \"evidence\": \"In vitro DNA repair assays with purified CUT domains, abasic site quantification, clonogenic survival in glioblastoma cells\",\n      \"pmids\": [\"29036362\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether CUX1 stimulates other BER enzymes (e.g., DNA polymerase β, ligase III) is untested\",\n        \"In vivo relevance of CUX1-mediated temozolomide resistance beyond cell lines not established\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"CUX1 haploinsufficiency in AML was mechanistically linked to de-repression of CFLAR (FLIP), establishing a direct tumor-suppressive circuit: CUX1 normally represses the CFLAR promoter, and its loss enables apoptosis evasion; a genome-wide CRISPR screen identified CFLAR as a selective vulnerability exploitable by IAP antagonists.\",\n      \"evidence\": \"Genome-wide CRISPR/Cas9 screen, ChIP, promoter reporter assays, murine and human AML models\",\n      \"pmids\": [\"33931647\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether CFLAR de-repression is the primary driver of CUX1-haploinsufficient AML or one of several effectors is unresolved\",\n        \"The co-repressor complex mediating CFLAR repression by CUX1 is not defined\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"CUX1 was connected to vascular aging by binding an atherosclerosis-associated SNP at the CDKN2A/B locus, regulating p16INK4a expression, and triggering senescence in endothelial cells upon oxidative or DNA damage stress.\",\n      \"evidence\": \"Post-GWAS SNP functional analysis, ChIP, CUX1 knockdown/overexpression, senescence assays in endothelial cells\",\n      \"pmids\": [\"37117763\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether CUX1 binding at rs1537371 is allele-specific in vivo is not fully resolved\",\n        \"Contribution of the BER function of CUX1 to the senescence phenotype at this locus is untested\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of CUT domain stimulation of BER enzymes, how isoform-specific functions are coordinated in vivo, and whether CUX1's transcriptional and DNA repair roles are integrated at sites of chromatin damage.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No crystal or cryo-EM structure of CUT domain bound to OGG1 or APE1\",\n        \"In vivo isoform-specific contributions during tissue homeostasis not separated by conditional genetics\",\n        \"Whether CUX1 transcriptional targets and BER function converge at replication-associated damage sites is unknown\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [2, 3, 4, 5, 14, 15, 20]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [2, 4, 5, 14, 23]},\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": [7, 8, 9]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [7, 8, 9]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 4, 7, 10, 14]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [0, 3, 4]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [7, 8, 9, 10, 11]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [2, 4, 5, 14, 15, 20]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [16, 20]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [17, 18, 19]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [12, 13, 24]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"E2F1\",\n      \"E2F2\",\n      \"OGG1\",\n      \"APE1\",\n      \"SATB1\",\n      \"TLE4\",\n      \"RELA\",\n      \"GLIS1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}